News
-
ACLA Letter to Michigan Medicaid on Cystic Fibrosis Testing
... -
ACLA Comments on CY 2019 OPPS Proposed Rule
... -
ACLA Statement on District Court Opinion in Lawsuit Against HHS
Lawsuit targeted HHS’ unlawful implementation of 2014 Medicare legislation, regulatory guidance that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – Following the opinion from the U.S. District Court for the District of Columbia in ACLA v. Azar, Julie Khani, ACLA President, issued the following statement: “This is an extremely disappointing outcome for ACLA’s members and the millions of seniors they serveContinue Reading »... -
Press Release; ACLA Submits Comments to Proposed 2019 Medicare Payment Policies
... -
ACLA Comments on CY 2019 PFS Proposed Rule
... -
ACLA Calls on CMS to Address Questionable Medicare Utilization Practices Through Stronger ‘Stark Law’ Provisions
Washington, D.C. – In a new comment letter to the Centers for Medicare & Medicaid Services (CMS), the American Clinical Laboratory Association called on the agency to address the long-standing abuse of the physician self-referral law (“Stark Law”) that has lead to persistent overutilization of specific services across the Medicare program. While CMS’ Request For Information on the Stark Law largely centered on howContinue Reading »... -
ACLA Comments on Request for Information Regarding the Physician Self-Referral Law
... -
AIM Coalition Urges CMS to Strengthen Medicare Self-Referral Provisions to Support Transition to Value-Based Care
Proposed Changes to Stark Law – Including Narrowing the In-Office Ancillary Services Exception – Would Save Medicare at Least $3.3 Billion Over Next Decade Washington, D.C. – The Medicare program could save at least $3.3 billion over the next decade by narrowing a persistent loophole in the physician self-referral law (“Stark Law”) that drives questionable utilization patterns for certain health services. The cost-savings proposalContinue Reading »... -
AIM Coalition Letter to CMS on the Physician Self-Referral Law
... -
ACLA Urges Congressional Leaders to Advance New Regulatory Framework for Diagnostic Tests
In Comments to Congress, ACLA Cites Concerns with the FDA’s New Proposals for Diagnostic Reform Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) calls on Congressional leaders to enact a distinct regulatory framework for diagnostics – a key goal outlined in comments to Reps. Larry Bucshon (R-IN) and Diana DeGette (D-CO), and Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO). The commentsContinue Reading »...
